Loncastuximab, CAS 1875032-68-0

Product Description: Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL)[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Zinzani PL, et al. Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma. J Cancer Res Clin Oncol. 2022 Jan;148(1):177-190. /[2]Hess B, et al. Efficacy and Safety Exposure-Response Analysis of Loncastuximab Tesirine in Patients with B cell non-Hodgkin Lymphoma. AAPS J. 2021 Dec 10;24(1):11.

CAS Number: 1875032-68-0

Molecular Weight: 144460

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CD19

• Artikelnummer: MEXHY-P99711-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99711-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated